Login
$ANIP
$70.84 -$0.60 (0.84%) Live

$ANIP SEC Filings

Filed On Filing
16 Nov 2026 144
16 Nov 2026 8-K: Regulation FD Disclosure

Date of Report (Date of Earliest Event Reported): November 16, 2026

13 Nov 2026 Form 4: Cook Meredith, SR. VP, GENERAL COUNSEL & SEC.

Sold 500 shares ($35.4K)

05 Nov 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more

CREDIT AGREEMENT, dated as of November 4, 2026, by and among ANI PHARMACEUTICALS, Inc., a Delaware corporation (the “Lead Borrower”), the Additional Subsidiary Borrowers (as hereinafter defined), the Guarantors (as hereinafter defined), ...

05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

PRINCETON, N.J., November 5, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the third quarter ended September 30, 2026.

30 Oct 2026 Form 4: Carey Stephen P., SVP & CFO

Sold 2,850 shares ($208K)

29 Oct 2026 144
16 Oct 2026 Form 4: Lalwani Nikhil, Director

Sold 5,400 shares ($388K)

15 Oct 2026 144
13 Oct 2026 Form 4: Cook Meredith, SR. VP, GENERAL COUNSEL & SEC.

Sold 500 shares ($36.8K)

30 Sep 2026 Form 4: Carey Stephen P., SVP & CFO

Sold 2,850 shares ($208K)

16 Sep 2026 Form 4: Lalwani Nikhil, Director

Sold 5,400 shares ($383K)

15 Sep 2026 144
14 Sep 2026 Form 4: Thoma Jeanne, Director

Sold 1,000 shares ($71.5K)

14 Sep 2026 Form 4: Cook Meredith, SR. VP, GENERAL COUNSEL & SEC.

Sold 500 shares ($35.4K)

11 Sep 2026 144
01 Sep 2026 Form 4: Carey Stephen P., SVP & CFO

Sold 2,850 shares ($207K)

27 Aug 2026 Form 4: Gosebruch Henry O, Director

Received 6,662 shares as a grant or award

27 Aug 2026 Form 3: Gosebruch Henry O, Director

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support